Cadmium may impair prostate function as measured by Prostate Specific Antigen in semen: a cross-sectional study among European and Inuit men.

Alessandro Andreucci, Emina Mocevic, Bo A Jönsson, Aleksander Giwercman, Yvonne Giwercman, Gunnar Toft, Thomas Lundh, Davide Bizzaro, Ina Olmer Specht, Jens Peter Bonde

Research output: Contribution to journalArticlepeer-review

Abstract

We investigated the association between cadmium in blood and the concentration of the prostate specific antigen (PSA) in semen, including the modifying effects of zinc or the CAG polymorphism in the androgen receptor (AR). Blood and semen samples were collected from 504 partners of pregnant women in Greenland, Poland and Ukraine. We found an inverse trend between cadmium and PSA (log (ß)= -0.121, 95% Confidence Interval (CI):-0.213; -0.029, P=0.0103) in Greenlandic men. Similar results were observed in men with a high number of CAG repeats (CAG 24) (log (ß)=-0.231, 95% CI:-0.363; -0.098, P=0.0009). Inverse trends between cadmium and PSA were found when semen zinc concentrations were below the median value for men from Ukraine and Greenland. These outcomes suggest that cadmium may impair prostate function, as measured by PSA in semen, while high zinc levels and a low number of CAG repeats protects against this action.
Original languageEnglish
Pages (from-to)33-38
JournalReproductive Toxicology
Volume53
Issue numberFeb 3
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Obstetrics, Gynecology and Reproductive Medicine

Fingerprint

Dive into the research topics of 'Cadmium may impair prostate function as measured by Prostate Specific Antigen in semen: a cross-sectional study among European and Inuit men.'. Together they form a unique fingerprint.

Cite this